Bookmark Article
The president signed an executive action to enhance enforcement against online pharmacies violating FDA regulations on drug advertising, directing the FDA and HHS Secretary Robert F. Kennedy Jr. to ensure transparency in advertising, including risk disclosures. The administration plans to issue around 100 cease-and-desist letters and address concerns over misleading ads, particularly those promoted by social media influencers.
Want More Context? 🔎
